Overview
Mary Beth-Son is a Pediatric Rheumatologist practicing medicine in Boston, Massachusetts.
Dr. Beth-Son is highly rated in 3 conditions, according to our data. Her clinical expertise encompasses Multisystem Inflammatory Syndrome in Children (MIS-C), Juvenile Dermatomyositis, Juvenile Idiopathic Arthritis (JIA), and Kawasaki Disease.
She is actively involved in clinical research, co-authoring 2 peer reviewed articles. Dr. Beth-Son is currently accepting new patients.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- POS
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE SNP
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- PPO
- HMO
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- OTHER COMMERCIAL
- HMO
- INDEMNITY
- POS
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- PPO
- OTHER MEDICAID
- STATE MEDICAID
- EPO
- MANAGED MEDICAID PLAN
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
300 Longwood Ave, Boston, MA 02115
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Division Of Immunology
Fatma Dedeoglu is a Pediatric Rheumatologist practicing medicine in Boston, Massachusetts. Dr. Dedeoglu is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Localized Scleroderma, Juvenile Idiopathic Arthritis (JIA), PFAPA, and Juvenile Dermatomyositis. Dr. Dedeoglu is currently accepting new patients.
Boston Children's Hospital
Robert Fuhlbrigge is a Pediatric Rheumatologist practicing medicine in Boston, Massachusetts. Dr. Fuhlbrigge is highly rated in 3 conditions, according to our data. His clinical expertise encompasses Localized Scleroderma, Juvenile Idiopathic Arthritis (JIA), Arthritis, and Systemic Lupus Erythematosus (SLE). Dr. Fuhlbrigge is currently accepting new patients.
Pediatric Rheumatology Program
Lauren Henderson is a Pediatric Rheumatologist practicing medicine in Boston, Massachusetts. Dr. Henderson is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Juvenile Idiopathic Arthritis (JIA), Multisystem Inflammatory Syndrome in Children (MIS-C), Arthritis, and Kawasaki Disease. Dr. Henderson is currently accepting new patients.
Frequently Asked Questions about Dr. Mary Beth-Son
How do I make an appointment with Dr. Mary Beth-Son?
You can book an appointment with Dr. Mary Beth-Son by calling their office at 617-355-6117. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Mary Beth-Son a top-rated expert for Multisystem Inflammatory Syndrome in Children (MIS-C)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Mary Beth-Son is classified as an Distinguished expert for Multisystem Inflammatory Syndrome in Children (MIS-C), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Mary Beth-Son specialize in?
While Dr. Mary Beth-Son is a Pediatric Rheumatology, they have specific expertise in Multisystem Inflammatory Syndrome in Children (MIS-C), Juvenile Dermatomyositis, and Juvenile Idiopathic Arthritis (JIA). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Pediatric Rheumatology.
Does Dr. Mary Beth-Son participate in research or clinical trials?
Yes. Dr. Mary Beth-Son has published 2 articles and abstracts on conditions like Multisystem Inflammatory Syndrome in Children (MIS-C). You can view a list of Dr. Mary Beth-Son's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Does Dr. Mary Beth-Son accept my insurance?
Dr. Mary Beth-Son accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 617-355-6117 to verify that your specific plan is currently accepted before your visit.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Distinguished
- Multisystem Inflammatory Syndrome in Children (MIS-C)
- Advanced
- Juvenile DermatomyositisDr. Beth-Son isAdvanced. Learn about Juvenile Dermatomyositis.
- Juvenile Idiopathic Arthritis (JIA)Dr. Beth-Son isAdvanced. Learn about Juvenile Idiopathic Arthritis (JIA).
- Experienced
- ArthritisDr. Beth-Son isExperienced. Learn about Arthritis.
- CHARGE SyndromeDr. Beth-Son isExperienced. Learn about CHARGE Syndrome.
- Discoid Lupus Erythematosus (DLE)Dr. Beth-Son isExperienced. Learn about Discoid Lupus Erythematosus (DLE).
- Kawasaki DiseaseDr. Beth-Son isExperienced. Learn about Kawasaki Disease.
- Koolen De Vries SyndromeDr. Beth-Son isExperienced. Learn about Koolen De Vries Syndrome.
- PIK3CA-Related Overgrowth SpectrumDr. Beth-Son isExperienced. Learn about PIK3CA-Related Overgrowth Spectrum.
- Psoriatic ArthritisDr. Beth-Son isExperienced. Learn about Psoriatic Arthritis.
- Pulmonary Alveolar ProteinosisDr. Beth-Son isExperienced. Learn about Pulmonary Alveolar Proteinosis.
- Systemic Lupus Erythematosus (SLE)Dr. Beth-Son isExperienced. Learn about Systemic Lupus Erythematosus (SLE).